The Effect of Anthropometrics on Desflurane Rise Time
Does Desflurane Take Longer to Reach Target Endtidal Concentration in Patients With Higher Body Muscle Content: a Pragmatic Study
1 other identifier
observational
361
1 country
1
Brief Summary
Desflurane is increasingly used in general anesthesia. Its pharmacokinetic properties are known and its distribution is easily modeled. Yet these models fail in practice. In order to increase accuracy, any model should include cardiac output, alveolar ventilation and alveolar dead space, all of which are either hard to measure or impractical, at least. A previous study performed by the same investigator showed that time to target endtidal concentration of sevoflurane is prolonged with increased cardiac output, but only if the patient has increased muscle mass. Although desflurane has lower muscle and fat solubility, our observations suggest a similar prolongation in case of increased muscle mass. The investigators aim to investigate if patient characteristics such as gender, age, height, weight, body type prolongs time to reach target endtidal desflurane concentration in low flow anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFirst Posted
Study publicly available on registry
September 6, 2023
CompletedDecember 22, 2023
December 1, 2023
1.6 years
March 31, 2023
December 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of rise in expiratory desflurane concentration
Correlation between the time required for the endtidal expiratory desflurane concentration to reach 8% and patient characteristics
intraoperative
Rate of rise in inspiratory desflurane concentration
Correlation between the time required for the endtidal inspiratory desflurane concentration to reach 6% and patient characteristics
intraoperative
Secondary Outcomes (2)
Correlation between occurrence of hypertension and patient characteristics
intraoperative
Correlation between occurrence of tachycardia and patient characteristics
intraoperative
Study Arms (1)
Patients scheduled for general anesthesia
Patients scheduled for elective general anesthesia will be included, if accepts and signs the informed consent. The inhalational anesthetic should be desflurane. No other inhalational agent should be used during the induction of anesthesia. The inspiratory and expiratory concentration of any inhalational agent should be zero before the induction of anesthesia.
Interventions
Following tracheal intubation, the fresh gas flow will be set to 1 liters/minute, desflurane vaporizer will be set to maximum.
Eligibility Criteria
Adult patients, who are scheduled for elective general anesthesia. Maintenance of anesthesia with desflurane should be included in the routine anesthesia plan.
You may qualify if:
- age \> 18 years
- planned elective surgery
- planned inhalational anesthesia
- planned use of desflurane
You may not qualify if:
- emergency surgery
- use of other inhalational anesthetic agent (sevoflurane, isoflurane, nitrous oxide)
- disclosed or recognized pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Recep Tayyip Erdogan University Medical Faculty, Department of Anesthesiology and Reanimation
Rize, 53100, Turkey (Türkiye)
Related Publications (3)
Weber J, Missbach C, Schmidt J, Wenzel C, Schumann S, Philip JH, Wirth S. Prediction of expiratory desflurane and sevoflurane concentrations in lung-healthy patients utilizing cardiac output and alveolar ventilation matched pharmacokinetic models: A comparative observational study. Medicine (Baltimore). 2021 Feb 12;100(6):e23570. doi: 10.1097/MD.0000000000023570.
PMID: 33578509RESULTAthiraman U, Ravishankar M, Jahagirdhar S. Performance of computer simulated inhalational anesthetic uptake model in comparison with real time isoflurane concentration. J Clin Monit Comput. 2016 Dec;30(6):791-796. doi: 10.1007/s10877-015-9776-6. Epub 2015 Sep 19.
PMID: 26386708RESULTPhilip JH. Using screen-based simulation of inhaled anaesthetic delivery to improve patient care. Br J Anaesth. 2015 Dec;115 Suppl 2:ii89-94. doi: 10.1093/bja/aev370.
PMID: 26658205RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Başar Erdivanlı, Assoc. Prof.
Recep Tayyip Erdogan University Medical Faculty, Department of Anesthesiology and Reanimation
- PRINCIPAL INVESTIGATOR
Alihan Madran, M.D.
Recep Tayyip Erdogan University Medical Faculty, Department of Anesthesiology and Reanimation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc Prof
Study Record Dates
First Submitted
March 31, 2023
First Posted
September 6, 2023
Study Start
February 1, 2022
Primary Completion
August 30, 2023
Study Completion
September 1, 2023
Last Updated
December 22, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share